Showing results (221-230 of 679) with videos related to

Sort By:
Pageof 68
Acta Neuropathologica|September 30, 2018
Structure and evolution of double minutes in diagnosis and relapse brain tumorsKe Xu, Liang Ding, Ti-Cheng Chang, et al.
Molecular and Cellular Biology|June 22, 2002
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formationMichaela Livia Bajenaru, Yuan Zhu, Nicolé M Hedrick, et al.
Neoplasia (New York, N.Y.)|December 4, 2018
KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 ProductionRan Chen, Chanel Keoni, Christopher A Waker, et al.
Neurology. Clinical Practice|August 25, 2018
Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1Jennifer L Griffith, Stephanie M Morris, Jasia Mahdi, et al.
Acta Neuropathologica|April 24, 2013
BRAF(V600E) mutation is a negative prognosticator in pediatric gangliogliomaSonika Dahiya, Devon H Haydon, David Alvarado, et al.
Nature Communications|May 11, 2022
A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genesWenan Chen, Shuoguo Wang, Saima Sultana Tithi, et al.
Human Molecular Genetics|November 11, 2010
Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complexLing-Hui Zeng, Nicholas R Rensing, Bo Zhang, et al.
The Journal of Pediatrics|June 2, 2015
Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1Salmafatima S Abadin, Nancy L Zoellner, Melody Schaeffer, et al.
Pageof 68